Study rationale and design EUROPA Study Investigators Lancet. 2003;362:782-788. ACE inhibition for secondary prevention of CAD Rationale Anti-atherosclerotic effects Plaque…
Study rationale and design EUROPA Study Investigators Lancet. 2003;362:782-788. ACE inhibition for secondary prevention of CAD Rationale Anti-atherosclerotic effects Plaque…